Original Article

Serological epidemiology analysis of Cytomegalovirus infection in pregnant women in Diwaniyah, Iraq

Abstract

Background and Objectives: Human cytomegalovirus (HCMV) infection is the most common cause of congenital infection during pregnancy. It is a major concern worldwide with a wide range of clinical outcomes in fetuses and newborns due to HCMV reactivation or reinfection during pregnancy. Primary maternal infection is best diagnosed by examining IgM and IgG antibodies. The current study aimed epidemiology survey of congenital HCMV infection in pregnant women in Diwaniyah.
Materials and Methods: 600 blood samples were collected from pregnant women, between 18-45 years old, in Diwaniyah Governorate for 12 months, from January to December 2022, in regards to their place of residence (urban or rural). All samples were monitored for both IgG and IgM antibodies against HCMV using rapid test and ELISA.
Results: Our findings showed a high positive rate for IgG (95.7%) and (96.2%) and a positive rate for IgM (1.5%) and (1.8%) for rapid test and ELISA, respectively. The highest IgG positive rate was in the age group 26-35 years (43.33%), while the lowest rate (13.0%) was in the age group 36-45 years. The HCMV infection rate in rural and urban areas were (96.48%) and (95.26%), respectively, with no significant differences (P value>0.05). Also, the rate of miscarriages among pregnant women infected with HCMV was 28.83%, and the highest infection rate (30.51%) was recorded in the age group 26-35 years.
Conclusion: The prevalence of HCMV infection and its related miscarriage among the studied population is relatively high with the highest rate in the age group of 26-35 years.

1. Chong ETJ, Suardi AFA, Lee PC. Pathogenicity and diagnostic methods of human cytomegalovirus. Borneo Int J Biotechnol 2023; 3: 100-111.
2. Fowler K, Mucha J, Neumann M, Lewandowski W, Kaczanowska M, Grys M, et al. A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development. BMC Public Health 2022; 22: 1659.
3. Bateman CM, Kesson A, Powys M, Wong M, Blyth E. Cytomegalovirus infections in children with primary and secondary immune deficiencies. Viruses 2021; 13: 2001.
4. Boyle M, Posada R. Congenital Cytomegalovirus. Pediatr Rev 2022; 43: 291-293.
5. Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol 2021; 19: 759-773.
6. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010; 20: 202-213.
7. Nso-Mangue P, Acosta T, Luján-Mora S (2024). Web Accessibility of Top-10 Universities of Africa, America, Asia, Europe, And Oceania: 2023 Snapshot. Conference: 18th International Technology, Education and Development Conference. pp. 5059-5068. https://library.iated.org/view/NSOMANGUE2024WEB2
8. Choodinatha HK, Jeon MR, Choi BY, Lee KN, Kim HJ, Park JY. Cytomegalovirus infection during pregnancy. Obstet Gynecol Sci 2023; 66: 463-476.
9. Uche Akunaeziri A, Charles A, Francis Ajang M, Amaka Ngozi O. Cytomegalovirus infection among women with recurrent miscarriages. Trop J Obstet Gynaecol 2021; 38: 128-138.
10. Saravi NM, Aghajani F, Najafi A, Khajavi R, Rahmani Z, Jalali H, et al. A seromolecular study to determine the prevalence of cytomegalovirus in pregnant women referred to health centers in the north of Iran. Iran J Microbiol 2023; 15: 594-600.
11. AL-Saeedi RJM, Al-Hadraawy MK, Abdulgabar ZS, Khudair K. Microbial factors causing recurrent miscarriage a survey study for women in the Al Najaf governorate, Iraq. AIP Conf Proc 2023; 2776: 020014.
12. Jahan M, Sultana N, Asma R, Tabassum S, Islam N. Birth prevalence of congenital Cytomegalovirus (CMV) infection in a cohort of pregnant women in Bangladesh. Bangladesh Med Res Counc Bull 2017; 43: 77-81.
13. Leber AL. Maternal and congenital human cytomegalovirus infection: laboratory testing for detection and diagnosis. J Clin Microbiol 2024; 62(4): e0031323.
14. Nanou C, Tigka M, Metallinou D. Congenital cytomegalovirus infection: A narrative review. World J Adv Res Rev 2024; 22: 1319-1325.
15. Grosse SD, Fleming P, Pesch MH, Rawlinson WD. Estimates of congenital cytomegalovirus-attributable infant mortality in high-income countries: A review. Rev Med Virol 2024; 34(1): e2502.
16. D'Alberti E, Rizzo G, Khalil A, Mappa I, Pietrolucci ME, Capannolo G, et al. Counseling in fetal medicine: Congenital cytomegalovirus infection. Eur J Obstet Gynecol Reprod Biol 2024; 295: 8-17.
17. Schattner A. The Wide Spectrum of presentations of cytomegalovirus infection in immunocompetent Hosts: An exhaustive narrative review. Pathogens 2024; 13: 667.
18. Shakir SKS, Akgun RO, Jabbar AA. Genotyping of cytomegalovirus glycoprotein n and GB and its relationship with abortion status in an Iraqi female sample. Int J Forensic Med 2023; 5: 5-10.
19. Radoi CL, Zlatian O, Balasoiu M, Dragomir TL, Sorop MI, Bagiu IC, et al. Seroprevalence of Anti- cytomegalovirus antibodies in pregnant women from South-West Romania. Microorganisms 2024; 12: 268.
20. Murshid MK, Abood WS. Evaluation of cytomegalovirus (CMV) IgM level and IgG Avidity in detection of primary infection in pregnant women. Ann Trop Med Public Health 2020; 23: 23-104.
21. Naqid IA, Yousif SH, Hussein NR. Serological Study of IgG and IgM antibodies to cytomegalovirus and toxoplasma infections in pregnant women in Zakho city, Kurdistan region, Iraq. Women Health Bull 2019; 6: 8-12.
22. Khikani AN, Firat M, Al-khafaji ZA. Association of hcmv-miR-UL36-5P Gene expression with Miscarriages in women with human cytomegalovirus infection in Babylon, Iraq. Al-Rafidain J Med Sci 2024; 7: 43-48.
23. Partana P, Wan WY, Chow XYV, Chan JKY, Tan LK, Tan WC, et al. Seroprevalence of cytomegalovirus among pregnant women in Singapore. Trop Med Health 2024; 52: 67.
24. Pourroostaei Ardakani P, Rahimi B, Panahi M, Sheykhi K, Karimian B, Rahimi H. Molecular investigation of association between common IL-6 polymorphism with cytomegalovirus (CMV) infection and recurrent miscarriage in Iranian women. Mol Biol Rep 2022; 49: 9499-9507.
25. Farshidi F, Abedi g, Mossazadeh M, Afshari M. Seroprevalence of cytomegalovirus antibodies and primary infection among women and infants in Iran: A meta-analysis. Iran J Cancer Prev 2017; 10(1): e3704.
Files
IssueVol 17 No 1 (2025) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v17i1.17810
Keywords
Human cytomegalovirus (HCMV); Pregnant women; Seroepidemiology
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Al-Zubaidi M, Hosseini SM, Al-Roudhan M, Al-Harmooshee M. Serological epidemiology analysis of Cytomegalovirus infection in pregnant women in Diwaniyah, Iraq. Iran J Microbiol. 2025;17(1):128-136.